USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 34,226 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $57.51, for a total transaction of $1,968,337.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

USANA Health Sciences, Inc. (NYSE:USNA) opened at 57.00 on Friday. The firm’s 50-day moving average is $57.61 and its 200-day moving average is $60.16. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.06 by ($0.08). USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company had revenue of $257.10 million for the quarter, compared to analyst estimates of $273.61 million. During the same period in the previous year, the business posted $2.07 EPS. The firm’s revenue for the quarter was down .5% compared to the same quarter last year. On average, equities analysts anticipate that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current year.

USANA Health Sciences announced that its board has authorized a share repurchase program on Tuesday, July 25th that authorizes the company to buyback $64.60 million in outstanding shares. This buyback authorization authorizes the company to buy up to 46% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/17/myron-w-wentz-sells-34226-shares-of-usana-health-sciences-inc-usna-stock.html.

Several research analysts recently commented on the stock. BidaskClub upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Pivotal Research reduced their price objective on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

A number of hedge funds have recently added to or reduced their stakes in the business. Alps Advisors Inc. increased its holdings in shares of USANA Health Sciences by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 8,349 shares of the company’s stock valued at $535,000 after acquiring an additional 22 shares during the period. California State Teachers Retirement System increased its holdings in shares of USANA Health Sciences by 0.5% in the 2nd quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after acquiring an additional 100 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of USANA Health Sciences by 1.2% in the 1st quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after acquiring an additional 196 shares during the period. Clinton Group Inc. increased its holdings in shares of USANA Health Sciences by 4.9% in the 1st quarter. Clinton Group Inc. now owns 5,238 shares of the company’s stock valued at $302,000 after acquiring an additional 245 shares during the period. Finally, BNP Paribas Arbitrage SA increased its holdings in shares of USANA Health Sciences by 13.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after acquiring an additional 245 shares during the period. 44.90% of the stock is currently owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.